Bay Area leaders started to break the glass ceiling at Berkeley City Club. On the Annual International Worker's Day, May 1st, the ISPE San Francisco | Bay Area Program Committee had the pleasure of hosting its' first Women in Pharma® (WIP) event. The sold-out event was held at the Berkeley City Club, also known as the "Little Castle" which was built in 1927 to honor the need for a women's activity center. In these historic rooms, ISPE had over 80 attendees (both men!!! and women) to join an exciting debate and panelist discussion, led by six strong women, all from leadership positions in the Bay Area, on how to unite and break the glass ceiling.
The role model panelists included:
Take-ways included a great quote and some answered questions:
"We shape our buildings, and afterwards, our buildings shape us"
So, why are there not more females in engineering? It all starts early in breaking the stereotypes. There are low female graduation rates due to a lack of female engineering role models, and misconceptions on what it is like to be an engineer. One topic about "Unconscious bias" gained a lot of interest during the evening. It was raised that female leaders, in particular, can be affected by a double-blind bias or the problem of a mismatch between what is expected of a leader, and what is expected from a woman. Damned if you do, damned if you don't. Too soft. Too tough. Never just right! And expressions like "She is such a bulldog" can be perceived in a negative for a women - while if it is a man that is a bulldog - then it might be a positive attribute.
So, is there any hope for the future generations? The panelists were all hopeful, however it is important that we don't stand still and as Andrea Karlsson noted "having role models means a lot in your development". At the same time we all need to be self-aware and establish diverse teams. Kathy Yi from Sangamo Therapeutics highlighted that diverse teams are performing better. Janet Wendorf from Bayer noted that she has seen more female junior engineers get involved in Bayer's own 'Women in Technology' program and it is great to see their passion. "It gives me hope that there are more young people in technology. That gives me hope to see more women at a higher level and that they are ready to speak-up when there is a bias".
It is hopefully not the last time that the ISPE San Francisco | Bay Area Chapter is hosting a Women in Pharma Event. As Kathy Yi mentioned "It would be wonderful if this room can be double the size in two years". Let's help each other to make that happen and get involved in Women in Pharma, men are welcome also! Women will never solve a leadership problem alone, everyone needs to be involved.
In the pharmaceutical industry, which is highly regulated, aseptic processing is a critical component that ensures the sterility of products. Regulators have a set of comprehensive requirements that minimize the risk of contamination. Regulators set the requirements; however, the industry has an obligation to the patients who rely on and expect a drug that is safe and free of contamination....
Like any investment in digital manufacturing systems, demonstrating business payback before and after investment is critical to getting MES projects approved and verifying profitability after investment. Whether it is introducing MES, expanding it to additional sites, switching software, upgrading existing software, or developing electronic production records (EPR) for new drug products,...
Sustainability is emerging as a pivotal force influencing the pharmaceutical industry’s dynamics and steering companies towards transformative change. The focus of this analysis is to delve into the sustainability key performance indicators (KPIs) of prominent pharmaceutical players, namely Pfizer, Sanofi, Glaxo Smith Kline (GSK), Becton Dickinson, Johnson & Johnson, Abbott, Eli Lilly, and...